Spanu, D., Ziranu, P., Pretta, A., Cerantola, R., Salani, F., Ortolani, S., Giacomo, E. D., D'Agata, A. P., Grelli, G., Mazzocca, A., Perissinotto, E., Pala, L., Mangogna, F., Lucchetti, J., Giampieri, R., Fornaro, L., Pastorino, A., Aprile, G., Nappo, F., Scartozzi, M. (2025). Development and validation of the gastric risk immuno-progression score (GRIPS) in advanced gastric and gastroesophageal junction adenocarcinoma treated with first-line chemotherapy plus nivolumab: Results from the ORACLE study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4062